Home LiteratureArticle Details
PMID: 23647917 Published · ppublish English

The ominous sequence in patients with tuberous sclerosis complex.

Brain & development ·Vol. 36 ·No. 3 ·2014-11-04

Yamada Hiroshi, Akiyoshi Kensuke, Izumi Tatsuro

Abstract

The clinical phenotypes and their severity in patients with tuberous sclerosis complex can be quite variable and are sometimes never determined simply by the primary mutation. These make clinically selecting appropriate treatments and predicting disease outcome difficult. In this report, the prognostic ominous sequence was evaluated in association with clinical manifestations and gene mutations.,The patients were classified by each renal lesion of angiomyolipomas and polycystic disease. The other clinical manifestations and outcomes of epilepsy, mental retardation, facial angiofibromas, subependymal giant cell astrocytoma, cortical tubers were reviewed and each gene mutations were analyzed in seven unrelated patients.,Two patients with multiple and large proliferative renal angiomyolipoma showed poor clinical outcome than the patients with other renal lesions. These patients presented with progressively proliferative facial angiofibroma, West syndrome, Lennox-Gastaut syndrome, severe mental retardation, subependymal giant cell astrocytoma and they were affected by TSC2 gene mutations.,The sequence of progressively proliferative renal angiomyolipoma, facial angiofibroma, West syndrome and TSC2 gene mutations might be prognostic ominous factors.

Keywords
Angiomyolipomas TSC1 TSC2 Tuberous sclerosis complex West syndrome
Article Info
Journal
Brain & development
Abbr.
Brain Dev
Published
2014-11-04
Indexed
2014-02-17
Updated
2014-02-17
Language
English
Country/Region
Netherlands
NLM ID
7909235
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]